Crohn's Disease and Tumor Necrosis Factor
Links shared publicly online about this topic
Are All Anti-tumor Necrosis Factor Antibodies the Same in Crohn’s Disease?—A Systematic Review with Commentary | Gastroenterology
touchgastroenterology.com — “Are All Anti-tumor Necrosis Factor Antibodies the Same in Crohn’s Disease?—A Systematic Review with Commentary” View full resource at touchgastroenterology.com
Most Recently Shared on July 7, 2011 at 12:29 pm By:
touchGASTRO Gastroenterology and Medical Journal
Are All Anti-tumor Necrosis Factor Antibodies the Same in Crohn’s Disease?—A Systematic Review with Commentary http://bit.ly/qcgX8s
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)” View full resource at fda.gov
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
Rheumatology Article | Cardiovascular Diseases Tumor Necrosis Factors Arthritis, Rheumatoid
mdlinx.com — “Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review” View full resource at mdlinx.com
Most Recently Shared on November 15, 2010 at 6:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumat... http://bit.ly/9HWQsQ #Rheumatology
Family Medicine Article | Cardiovascular Diseases Tumor Necrosis Factors Arthritis, Rheumatoid
mdlinx.com — “Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review” View full resource at mdlinx.com
Most Recently Shared on November 22, 2010 at 7:00 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumato... http://bit.ly/b5e8rb #FamPractice
Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA
health.msn.com — “Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA” View full resource at health.msn.com
Most Recently Shared on August 4, 2009 at 9:44 pm By:
Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA http://bit.ly/1LasF
Medical News: Earlier Biologic Use Boosts Remission in Crohn's Disease - in Gastroenterology, Inflammatory Bowel Disease from MedPage Today
medpagetoday.com — “The addition of an anti-tumor necrosis factor (TNF) biologic agent early in the course of Crohn's disease may improve the likelihood of clinical remission and possibly modify the course of the disease” View full resource at medpagetoday.com
Most Recently Shared on April 14, 2010 at 9:41 pm By:
Earlier Biologic Use Boosts Remission in Crohn's Disease (CME/CE, with audio) The addition of an anti-tumor necrosis fa.. http://dld.bz/ap3q
Rheumatology Medical News about Chickenpox Herpes Zoster Tumor Necrosis Factors
mdlinx.com — “Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists” View full resource at mdlinx.com
Most Recently Shared on June 24, 2010 at 9:49 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic disea... http://bit.ly/djCahF #Rheumatology
Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases - — JAMA
jama.ama-assn.org — “Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases - — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 6, 2011 at 10:55 pm By:
Some drugs to treat #autoimmunediseases do not appear to increase risk of hospitalization. JAMA online from #ACR2011 http://t.co/tHeyLOeC
Medical News: DDW: New Biologic Helps Severe Crohn's Disease - in Meeting Coverage, DDW from MedPage Today
medpagetoday.com — “CHICAGO -- Patients with active Crohn's disease who are unresponsive to treatment with tumor necrosis factor (TNF) inhibitors may have a new therapeutic option in ustekinumab (Stelara), researchers su” View full resource at medpagetoday.com
Most Recently Shared on September 15, 2011 at 9:26 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: DDW: New Biologic Helps Severe Crohn's Disease - http://t.co/1TnAmmVw from @medpagetoday #health #medicine
DDW: New Biologic Helps Severe Crohn's Disease (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “CHICAGO (MedPage Today) -- Patients with active Crohn's disease who are unresponsive to treatment with tumor necrosis factor (TNF) inhibitors may have a new therapeutic option in ustekinumab (Stelara), researchers suggested here.” View full resource at qualitypointtech.net
Most Recently Shared on May 10, 2011 at 9:45 pm By:
DDW: New Biologic Helps Severe Crohn's Disease (CME/CE): CHICAGO (MedPage Today) -- Patients with active Crohn's... http://bit.ly/muWzYr
Adalimumab - An Effective and Promising Treatment for Patients With Fistulizing Crohn's Disease: A Case Series - QualityPoint Technologies
qualitypointtech.net — “Adalimumab, a fully human anti-tumor necrosis factor monoclonal antibody, has been suggested as a safe and effective treatment in fistulizing Crohn's disease. How effective was it in these patients? Journal of Medical Case Reports” View full resource at qualitypointtech.net
Most Recently Shared on June 1, 2011 at 1:00 pm By:
Adalimumab - An Effective and Promising Treatment for Patients With Fistulizing Crohn's Disease: A Case Series: A... http://bit.ly/k6bfby
Phase 2b Data Show Treatment With Stelara Induced and Maintained Clinical Response in Patients With Moderate to Severe Crohn's Disease - Drugs.com MedNews
drugs.com — “Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists New study findings showed that t” View full resource at drugs.com
Most Recently Shared on May 9, 2011 at 3:09 pm By:
Drugs and Devices OW OW Health
Phase 2b Data Show Treatment With Stelara Induced and Maintained Clinical Response in Patients With Modera... http://bit.ly/kw7UYf #drug
FDA Drug Safety Communication: Safety Review update on reports of Hepatosplenic T-Cell Lymphoma in adolescents and young adults receiving tumor necrosis factor (TNF) blockers, azathioprine and/or mercaptopurine
fda.gov — “[04-14-2011] The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn--™s disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, as well as with azathioprine, and/or mercaptopurine.” View full resource at fda.gov
Most Recently Shared on April 14, 2011 at 3:02 pm By:
Richard Hom OD MPA Active Health Library, Doctor, and Optometrist
FDA ..Do you have patients taking tumor necrosis factor (TNF) blockers, azathioprine and/or mercaptopurine? Please read http://ow.ly/4AgL6
Tumor Necrosis Factor Inhibitors May Decrease MI Risk in Psoriasis - QualityPoint Technologies
qualitypointtech.net — “Tumor necrosis factor inhibitors might decrease the risk for myocardial infarction (MI) in patients with psoriasis. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on February 11, 2011 at 1:35 pm By:
Tumor Necrosis Factor Inhibitors May Decrease MI Risk in Psoriasis: Tumor necrosis factor inhibitors might decreas... http://bit.ly/gmBG6j
Rheumatology Medical News about Behcet Syndrome Tumor Necrosis Factors Polymorphism, Genetic
mdlinx.com — “TNF Polymorphisms in Patients with Behcet Disease: A Meta-analysis” View full resource at mdlinx.com
Most Recently Shared on May 19, 2010 at 1:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
TNF Polymorphisms in Patients with Behcet Disease: A Meta-analysis: Archives of Medical Research http://bit.ly/bJphkC #Rheumatology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
touchGASTRO
Touch GASTROENTEROLOGY is a medical journal informing professions about the latest advances. Including fighting Ulcerative colitis & fields such as Rheumatology
-
SpineUniverse
Reporting on the health of your back, spine, and neck - www.spineuniverse.com
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
